Eli Lilly and Co (LLY.NO)
34.30
+0.44
(+1.30%)
CAD |
NEO |
Sep 19, 15:58
Eli Lilly Enterprise Value: 1.153T for Sept. 18, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
September 18, 2024 | 1.153T |
September 17, 2024 | 1.156T |
September 16, 2024 | 1.179T |
September 13, 2024 | 1.178T |
September 12, 2024 | 1.192T |
September 11, 2024 | 1.174T |
September 10, 2024 | 1.149T |
September 09, 2024 | 1.159T |
September 06, 2024 | 1.152T |
September 05, 2024 | 1.162T |
September 04, 2024 | 1.205T |
September 03, 2024 | 1.217T |
August 30, 2024 | 1.221T |
August 29, 2024 | 1.197T |
August 28, 2024 | 1.211T |
August 27, 2024 | 1.216T |
August 26, 2024 | 1.211T |
August 23, 2024 | 1.212T |
August 22, 2024 | 1.215T |
August 21, 2024 | 1.213T |
August 20, 2024 | 1.211T |
August 19, 2024 | 1.176T |
August 16, 2024 | 1.175T |
August 15, 2024 | 1.185T |
August 14, 2024 | 1.189T |
Date | Value |
---|---|
August 13, 2024 | 1.161T |
August 12, 2024 | 1.128T |
August 09, 2024 | 1.139T |
August 08, 2024 | 1.079T |
August 07, 2024 | 990.34B |
August 06, 2024 | 1.019T |
August 02, 2024 | 1.031T |
August 01, 2024 | 1.065T |
July 31, 2024 | 1.031T |
July 30, 2024 | 1.014T |
July 29, 2024 | 1.036T |
July 26, 2024 | 1.030T |
July 25, 2024 | 1.054T |
July 24, 2024 | 1.102T |
July 23, 2024 | 1.124T |
July 22, 2024 | 1.108T |
July 19, 2024 | 1.099T |
July 18, 2024 | 1.087T |
July 17, 2024 | 1.159T |
July 16, 2024 | 1.203T |
July 15, 2024 | 1.214T |
July 12, 2024 | 1.212T |
July 11, 2024 | 1.196T |
July 10, 2024 | 1.202T |
July 09, 2024 | 1.193T |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
716.33B
Minimum
Oct 03 2023
1.221T
Maximum
Aug 30 2024
957.74B
Average
973.26B
Median
Enterprise Value Benchmarks
Planet 13 Holdings Inc | 244.26M |
Trulieve Cannabis Corp | 3.017B |
The Hempshire Group Inc | -- |
Ascend Wellness Holdings Inc | 417.38M |
Bright Minds Biosciences Inc | 0.3715M |
Enterprise Value Related Metrics
Net Income (Quarterly) | 4.060B |
Revenue (Quarterly) | 15.47B |
Total Expenses (Quarterly) | 9.421B |
EPS Diluted (Quarterly) | 0.1224 |
Gross Profit Margin (Quarterly) | 80.80% |
Profit Margin (Quarterly) | 26.25% |
Earnings Yield | 0.88% |
Operating Earnings Yield | 1.69% |
Normalized Earnings Yield | 1.308 |